HIGHLIGHTS
- who: Qun Wang and collaborators from the Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany have published the article: CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model, in the Journal: Cells 2022, 2027 of 25/06/2022
- what: The authors assessed the effect of CCL22 on the expression of M2a marker CD206 by flowcytometry and revealed that CCL22 could be a therapeutic target for cervical cancer, which might be due to its role in regulating macrophage polarization. The study has demonstrated that CCL22 was secreted from TAMs but . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.